Fisher Paykel ICONFisher & Paykel Healthcare reported record growth for the year ending March 31, 2013 led by the success of its respiratory and acute care and obstructive sleep apnea product groups.
“Enthusiastic customer acceptance of our easy to fit, comfortable, and effective Pilairo nasal pillows and Eson nasal masks drove OSA mask revenue growth of 16% in the second half, in constant currency,” said Michael Daniell, CEO. “Early indications are that our recently introduced Simplus full-face mask will also be very well accepted.”
Respiratory and acute care product group operating revenue grew 18% and obstructive sleep apnea product group operating revenue grew 10% in constant currency, compared to the prior year second half. The growth helped fuel a record net profit after tax of NZ$77.1 million for the year ended March 31, 2013, an increase of 20% compared to the prior year.
Throughout the year, the company continued to expand its product and process research and development activities. Current new product projects include masks, flow generators, humidifier systems, and respiratory and acute care consumables.
Recent product developments include the launch of the new ICON+ flow generator range.
“Our new ICON+ flow generator range is rolling out to our major markets at present, and combines very simple setup with our comfort enhancing SensAwake and ThermoSmart systems and our efficient cloud-based Info Technologies for compliance data recording and reporting,” Daniell said.
Daniell anticipates further success as the company rolls out additional products.
“We expect our underlying revenue growth to continue to be robust, driven by a broad range of new products and applications,” he said.